Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.

@article{Waanders2009CarbohydrateA1,
  title={Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.},
  author={Esm{\'e} Waanders and Loes van Keimpema and Johannes T. Brouwer and Martijn G H van Oijen and Raymond Aerts and Fred C G J Sweep and Frederik Nevens and Joost P H Drenth},
  journal={Liver international : official journal of the International Association for the Study of the Liver},
  year={2009},
  volume={29 9},
  pages={
          1389-95
        }
}
  • Esmé Waanders, Loes van Keimpema, +5 authors Joost P H Drenth
  • Published in
    Liver international…
    2009
  • Medicine
  • BACKGROUND/AIMS Carbohydrate antigen 19-9 (CA19-9) is used as a biomarker to differentiate benign from malignant gastrointestinal disorders. We examined the value of CA19-9 measurement in polycystic livers after observing high CA19-9 cyst fluid levels in a benign polycystic liver case. METHODS We determined CA19-9 levels in serum (n=120) and hepatic cyst fluid (n=81), from patients with polycystic livers (n=109) and simple hepatic cysts (n=24). Further, we analysed CA19-9 expression in normal… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 28 CITATIONS

    Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.

    • François Jouret, Renaud Lhommel, +4 authors Nada Kanaan
    • Medicine
    • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
    • 2012
    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Case Report of Large Simple Hepatic cyst

    • Dr. M. Ramaswamy Naik, Dr. V. Venkata Rama Bai
    • 2019
    VIEW 1 EXCERPT
    CITES BACKGROUND

    An update on the pathophysiology and management of polycystic liver disease.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Gastrointestinal Manifestations of Autosomal‐Dominant Polycystic Kidney Disease

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Genetics and mechanisms of hepatic cystogenesis.

    VIEW 2 EXCERPTS
    CITES BACKGROUND